In case anyone missed this presentation.
https://www.aats.org/resources/lb4-prospective-single-center-randomized-control-trial-to-evaluate-the-safety-and-feasibility-of-a-novel-allogenic-mesenchymal-precursor-cell-therapy-in-patients-with-hypoplastic-left-heart-syndrome-2
Doctors are impatient for this stem cell therapy for their patients… not my words but
rather the words from a doctor during question time.
Well done to Boston’s Children’s Hospital for trailblazing this new treatment… again a doctor’s words, not mine.
Bring on MSB’s Phase 3 trial
- Forums
- ASX - By Stock
- MSB
- Ann: FDA Grants Rare Pediatric Disease Designation for Revascor
Ann: FDA Grants Rare Pediatric Disease Designation for Revascor, page-223
- There are more pages in this discussion • 158 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
|
|||||
Last
$1.08 |
Change
-0.010(0.92%) |
Mkt cap ! $1.233B |
Open | High | Low | Value | Volume |
$1.10 | $1.11 | $1.05 | $5.002M | 4.632M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 5697 | $1.08 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.09 | 1000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 5697 | 1.080 |
4 | 52546 | 1.070 |
2 | 13300 | 1.060 |
4 | 39265 | 1.055 |
7 | 46184 | 1.050 |
Price($) | Vol. | No. |
---|---|---|
1.085 | 1000 | 1 |
1.090 | 64118 | 2 |
1.095 | 25760 | 3 |
1.100 | 16660 | 3 |
1.105 | 50000 | 2 |
Last trade - 16.10pm 14/06/2024 (20 minute delay) ? |
|
|||||
Last
$1.09 |
  |
Change
-0.010 ( 0.10 %) |
|||
Open | High | Low | Volume | ||
$1.09 | $1.11 | $1.06 | 1181223 | ||
Last updated 15.59pm 14/06/2024 ? |
Featured News
MSB (ASX) Chart |